top of page
  • Writer's picturePhilip Hockberger

CBRE Report: Strong Growth Of Life Sciences Sector Favors Real Estate In Select Markets

Updated: May 18, 2019

March 6, 2019 by Kris Hudson

CBRE Analysis Finds Boston, San Francisco, San Diego Remain Unrivaled Life Sciences Capitals; Fast Risers Include Seattle, Houston, Austin

The U.S. life sciences industry and the real estate that it occupies have ridden a wave of momentum into this year that has positioned various industry hubs, from cornerstones such as Boston to emerging hotspots like Seattle, for outsized growth, according to a new report from CBRE.

Numerous indicators point to robust expansion for the industry, including the 86 percent increase in venture-capital funding for U.S. life sciences companies to $15.8 billion for the year ended in September from the previous year. Additionally, life sciences lab space under construction in the industry’s five largest U.S. markets expanded by 101 percent last year to 6.0 million sq. ft.

" CBRE’s report focuses on the human life-sciences industry, which encompasses manufacturing, testing and research-and-development work in the fields of biotechnology, pharmaceuticals and medical devices."

That momentum has several markets ascendant on CBRE’s ranking of the top established and emerging life sciences hubs. New York City, for example, stands to nearly double its inventory of lab space over the next two years, has posted the strongest growth in funding from the National Institutes of Health among major life sciences hubs, and boasts one of the highest concentrations of specialized life scientists.

Top 10 Established Life Sciences Markets

1) Boston-Cambridge 2) San Francisco Bay Area 3) San Diego 4) New Jersey 5) Raleigh-Durham 6) Washington, D.C.-Baltimore 7) New York City 8) Philadelphia 9) Los Angeles 10) Chicago

7 views0 comments

Recent Posts

See All

Mansueto, Polsky back Northwestern biotech spinout

by John Pletz, Carin's Chicago Business, May 6, 2021 A Northwestern University drug-development spinout has raised $4 million from investors including Morningstar founder Joe Mansueto. Grove Biopharma

CBIA and WIB partner on Work-Life Integration Survey

CBIA and Women In Bio (WIB) have published results of a survey that addresses the needs of professional women working in the life sciences. "The concept of work–life integration reflects a growing des


bottom of page